DB
CLPT icon

Dmitry Balyasny’s ClearPoint Neuro CLPT Stock Holding History

Dmitry Balyasny’s Portfolio CLPT Stock Details CLPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$892 Buy
+50
New +$625 ﹤0.01% 2950
2026
Q1 		– Sell
-217,274
Closed -$2.97M – 2957
2025
Q4 		$2.97M Buy
+217,274
New +$4.03M ﹤0.01% 1671
2025
Q2 		– Sell
-51,737
Closed -$615K – 2888
2025
Q1 		$615K Buy
51,737
+34,463
+200% +$536K ﹤0.01% 2198
2024
Q4 		$266K Buy
+17,274
New +$224K ﹤0.01% 2437
2023
Q1 		– Sell
-14,361
Closed -$122K – 2709
2022
Q4 		$122K Buy
+14,361
New +$136K ﹤0.01% 2222

Other funds holding CLPT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MCO
MAK Capital One New York $714M AUM 68.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
LG
Lane Generational Dover, Massachusetts $114M AUM 43.8% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
CFM
Compass Financial Management Tampa, Florida $829M AUM

Dmitry Balyasny's CLPT Position: Q2 2026 in Review

Dmitry Balyasny opened a new position in ClearPoint Neuro (CLPT) in Q2 2026: 50 shares worth $892. The stake represents ﹤0.01% of the portfolio and ranks #2950 among its holdings. This is a return to the name: Dmitry Balyasny previously reported a position in CLPT as recently as Q4 2025.

Dmitry Balyasny first reported a position in CLPT in Q4 2022 and has held it in 5 quarters since. The position peaked at $2.97M in Q4 2025. 128 funds tracked by Wall St. Rank hold CLPT as of Q2 2026.

  • Dmitry Balyasny held 50 shares of ClearPoint Neuro worth $892 as of Q2 2026.
  • ClearPoint Neuro was a new Dmitry Balyasny position in Q2 2026.
  • ClearPoint Neuro made up ﹤0.01% of Dmitry Balyasny's portfolio in Q2 2026, its #2950 holding.
  • Dmitry Balyasny first reported a position in ClearPoint Neuro in Q4 2022 and has held it in 5 quarters since.
  • Dmitry Balyasny's ClearPoint Neuro position peaked at $2.97M in Q4 2025.
  • 128 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q2 2026.

Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.